Casey Neal, C.P.A, joined StrideBio as the Controller in December 2019. Mr. Neal has over 10 years of experience across a broad range of finance areas, including financial reporting, compliance and business processes. As Controller, Mr. Neal is responsible for overseeing all accounting activities of the company.
Prior to joining StrideBio, Mr. Neal was the Controller of Selenity Therapeutics, a pre-clinical pharmaceutical discovery and development company, the Accounting Manager of Viamet Pharmaceuticals, a clinical-stage pharmaceutical company and a Senior Associate at EY in the Audit and Assurances practice.
Mr. Neal is a C.P.A. and holds an M.S.A. from Wake Forest University and a B.S. degree from the University of North Carolina at Wilmington, where he majored in Economics and Finance.